The added value of 18-fluorodeoxyglucose-positron emission tomography in the diagnosis of the behavioral variant of frontotemporal dementia

American Journal of Alzheimer's Disease and other Dementias

Volumn 29, Issue 7, 2014, Pages 607-613

  Kerklaan, B J ^a,b,c   Van Berckel, B N M ^d   Herholz, K ^e   Dols, A ^a   Van Der Flier, W M ^a   Scheltens, P ^a   Pijnenburg, Y A L ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

^c ZAANS MEDICAL CENTER   (Netherlands)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^e UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

behavior variant frontotemporal dementia; behavioral neurology; diagnostics; functional imaging; magnetic resonance imaging; psychiatry

Indexed keywords

FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

ADJUSTMENT DISORDER; ADULT; ALZHEIMER DISEASE; ARTICLE; BIPOLAR DISORDER; DEGENERATIVE DISEASE; DEPRESSION; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DIFFUSE LEWY BODY DISEASE; FACTITIOUS DISEASE; FEMALE; FOLLOW UP; FRONTAL VARIANT FRONTOTEMPORAL DEMENTIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MIDDLE AGED; MULTIINFARCT DEMENTIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PERSONALITY DISORDER; POSITRON EMISSION TOMOGRAPHY; PROGRESSIVE SUPRANUCLEAR PALSY; SENSITIVITY AND SPECIFICITY; TEMPORAL LOBE EPILEPSY; CEREBROSPINAL FLUID; DIAGNOSTIC USE; ELECTROENCEPHALOGRAPHY; FRONTOTEMPORAL DEMENTIA; NEUROIMAGING; NEUROPSYCHOLOGICAL TEST; PROCEDURES; RETROSPECTIVE STUDY; SCINTISCANNING;

CEREBROSPINAL FLUID; DIAGNOSIS, DIFFERENTIAL; ELECTROENCEPHALOGRAPHY; FEMALE; FLUORODEOXYGLUCOSE F18; FRONTOTEMPORAL DEMENTIA; HUMANS; MALE; MIDDLE AGED; NEUROIMAGING; NEUROPSYCHOLOGICAL TESTS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 84911085659     PISSN: 15333175     EISSN: 19382731     Source Type: Journal    
DOI: 10.1177/1533317514524811     Document Type: Article

References (38)

1. Neary D, Snowden JS, Gustafson L, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology. 1998 ; 51 (6). 1546-1554
2. Knopman DS, Boeve BF, Parisi JE, et al. Antemortem diagnosis of frontotemporal lobar degeneration. Ann Neurol. 2005 ; 57 (4). 480-488
3. Mendez MF. The accuracy of clinical criteria for the diagnosis of frontotemporal dementia. Int J Psychiatry Med. 2004 ; 34 (2). 125-130
4. Piguet O, Hornberger M, Shelley BP, Kipps CM, Hodges JR. Sensitivity of current criteria for the diagnosis of behavioral variant frontotemporal dementia. Neurology. 2009 ; 72 (8). 732-737
5. Pijnenburg YA, Mulder JL, van Swieten JC, et al. Diagnostic accuracy of consensus diagnostic criteria for frontotemporal dementia in a memory clinic population. Dement Geriatr Cogn Disord. 2008 ; 25 (2). 157-164
6. Rascovsky K, Hodges JR, Kipps CM, et al. Diagnostic criteria for the behavioral variant of frontotemporal dementia (bvFTD): current limitations and future directions. Alzheimer Dis Assoc Disord. 2007 ; 21 (4). S14 - S18
7. Gregory CA, Hodges JR. Clinical features of frontal lobe dementia in comparison to Alzheimer's disease. J Neural Transm Suppl. 1996 ; 47: 103-123
8. Panegyres PK, Graves A, Frencham KA. The clinical differentiation of fronto-temporal dementia from psychiatric disease. Neuropsychiatr Dis Treat. 2007 ; 3 (5). 637-645
9. Mendez MF, Shapira JS, McMurtray A, Licht E, Miller BL. Accuracy of the clinical evaluation for frontotemporal dementia. Arch Neurol. 2007 ; 64 (6). 830-835
10. Woolley JD, Khan BK, Murthy NK, Miller BL, Rankin KP. The diagnostic challenge of psychiatric symptoms in neurodegenerative disease: rates of and risk factors for prior psychiatric diagnosis in patients with early neurodegenerative disease. J Clin Psychiatry. 2011 ; 72 (2). 126-133
11. Varma AR, Snowden JS, Lloyd JJ, Talbot PR, Mann DM, Neary D. Evaluation of the NINCDS-ADRDA criteria in the differentiation of Alzheimer's disease and frontotemporal dementia. J Neurol Neurosurg Psychiatry. 1999 ; 66 (2). 184-188
12. Mendez MF, Selwood A, Mastri AR, Frey WH. Pick's disease versus Alzheimer's disease: a comparison of clinical characteristics. Neurology. 1993 ; 43 (2). 289-292
13. Rosen HJ, Hartikainen KM, Jagust W, et al. Utility of clinical criteria in differentiating frontotemporal lobar degeneration (FTLD) from AD. Neurology. 2002 ; 58 (11). 1608-1615
14. Rascovsky K, Hodges JR, Knopman D, et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain. 2011 ; 134 (pt 9). 2456-2477
15. Josephs KA, Whitwell JL, Jack CR, Parisi JE, Dickson DW. Frontotemporal lobar degeneration without lobar atrophy. Arch Neurol. 2006 ; 63 (11). 1632-1638
16. Koedam EL, Van der Flier WM, Barkhof F, Koene T, Scheltens P, Pijnenburg YA. Clinical characteristics of patients with frontotemporal dementia with and without lobar atrophy on MRI. Alzheimer Dis Assoc Disord. 2010 ; 24 (3). 242-247
17. Kipps CM, Davies RR, Mitchell J, Kril JJ, Halliday GM, Hodges JR. Clinical significance of lobar atrophy in frontotemporal dementia: application of an MRI visual rating scale. Dement Geriatr Cogn Disord. 2007 ; 23 (5). 334-342
18. Herholz K, Carter SF, Jones M. Positron emission tomography imaging in dementia. Br J Radiol. 2007 ; 80 (spec no 2): S160 - S167
19. Videbech P. PET measurements of brain glucose metabolism and blood flow in major depressive disorder: a critical review. Acta Psychiatr Scand. 2000 ; 101 (1). 11-20
20. Erkwoh R, Sabri O, Steinmeyer EM, Büll U, SaH. Psychopathological and SPECT findings in never-treated schizophrenia. Acta Psychiatr Scand. 1997 ; 96 (1). 51-57
21. Sachdev P, Brodaty H, Rose N, Haindl W. Regional cerebral blood flow in late-onset schizophrenia: a SPECT study using 99mTc-HMPAO. Schizophren Res. 1997 ; 27 (2-3). 105-117
22. Kipps CM, Hodges JR, Fryer TD, Nestor PJ. Combined magnetic resonance imaging and positron emission tomography brain imaging in behavioural variant frontotemporal degeneration: refining the clinical phenotype. Brain. 2009 ; 132 (pt 9). 2566-2578
23. McKeith IG, Galasko D, Kosaka K, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology. 1996 ; 47 (5). 1113-1124
24. McKeith IG, Dickson DW, Lowe J, et al. Diagnosis and management of dementia with Lewy bodies. third report of the DLB consortium. Neurology. 2005 ; 65 (12). 1863-1872
25. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of department of health and human services task force on Alzheimer's disease. Neurology. 1984 ; 34 (7). 939-944
26. Roman GC, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN international workshop. Neurology. 1993 ; 43 (2). 250-260
27. Wattjes MP. Structural MRI. Int Psychogeriatr. 2011 ; 23(suppl 2): S13 - S24
28. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state." A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1995 ; 12 (3). 189-198
29. Dubois B, Slachevsky A, Litvan I, Pillon B. The FAB: a frontal assessment battery at bedside. Neurology. 2000 ; 55 (11). 1621-1626
30. Morris JC. Clinical dementia rating: a reliable and valid diagnostic and staging measure for dementia of the Alzheimer type. Int Psychogeriatr. 1997 ; 9 (suppl 1): 173-176
31. Brix G, Zaers J, Adam LE, et al. Performance evaluation of a whole-body PET scanner using the NEMA protocol. national electrical manufacturers association. J Nucl Med. 1997 ; 38 (10). 1614-1623
32. Herholz K, Salmon E, Perani D, et al. Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET. Neuroimage. 2002 ; 17 (1). 302-316
33. Koenigs M, Grafman J. The functional neuroanatomy of depression: distinct roles for ventromedial and dorsolateral prefrontal cortex. Behav Brain Res. 2009 ; 201 (2). 239-243
34. Khan BK, Yokoyama JS, Takada LT, et al. Atypical, slowly progressive behavioural variant frontotemporal dementia associated with C9ORF72 hexanucleotide expansion. J Neurol Neurosurg Psychiatry. 2012 ; 83 (4). 358-364
35. Kipps CM, Hodges JR, Hornberger M. Nonprogressive behavioural frontotemporal dementia: recent developments and clinical implications of the 'bvFTD phenocopy syndrome'. Curr Opin Neurol. 2010 ; 23 (6). 628-632
36. Diehl-Schmid J, Grimmer T, Drzezga A, et al. Decline of cerebral glucose metabolism in frontotemporal dementia: a longitudinal 18F-FDG-PET-study. Neurobiol Aging. 2007 ; 28 (1). 42-50
37. Kertesz A, McMonagle P, Blair M, Davidson W, Munoz DG. The evolution and pathology of frontotemporal dementia. Brain. 2005 ; 128 (pt 9). 1996-2005
38. Krudop WA, Kerssens CJ, Dols A, et al. Building a new paradigm for the early recognition of behavioural variant frontotemporal dementia: the late onset frontal lobe syndrome-study (LOF-study) [published online June 25, 2013]. Am J Geriatr Psychiatry. 2013 ;: